Inari Medical Announces IDE Approval To Study The Flowtriever System For The Treatment Of Pulmonary Embolism

IRVINE, CALIFORNIA – March 8, 2016 – Inari Medical, Inc. announced today that it has received an Investigational Device Exemption (“IDE”) for a study to evaluate the safety and effectiveness of the FlowTriever Retrieval/Aspiration System. Ken Rosenfield, MD, Section Head for Vascular Medicine and Intervention, Massachusetts General Hospital and Victor Tapson, MD, Associate Director, Pulmonary and Critical Care Division, Cedars-Sinai Medical Center, Los Angeles are the Co-Principal Investigators of the study.

+ Read More

Inari Medical And Inceptus Medical Announce Receipt Of TCT Innovation Award

IRVINE, CALIFORNIA, November 23, 2015 – Inari Medical, Inc. and Inceptus Medical LLC announced today that the Inari FlowTriever® Retrieval /Aspiration System for thrombectomy received a 1st place Innovation Award at the 2015 Transcatheter Therapeutics (TCT) conference in San Francisco.

“We are pleased to have the FlowTriever thrombectomy system showcased at such a large and prestigious venue as TCT,” says Bill Hoffman, President and CEO of Inari. Bob Rosenbluth, President of Inceptus added, “We are proud to have Inari get this recognition at the largest medical device conference for interventional therapy. This is a nice honor as we initiate our pivotal trial to investigate the use of the FlowTriever specifically for the treatment of pulmonary embolism.”

+ Read More